# Terumo Blood and Cell Technologies

Source: https://onco.cc/companies/terumo-bct/  
OnCo record `terumo-bct` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Maker of the Spectra Optia apheresis system used to collect cells for most CAR-T products, and of the Quantum cell-expansion system.

## Summary

Terumo Blood and Cell Technologies, based in Lakewood, Colorado, and a subsidiary of Japan's Terumo, makes the Spectra Optia apheresis system used to collect cells for most CAR-T products, and the Quantum cell expansion system. Its portfolio covers apheresis, blood component and cell therapy manufacturing devices. OnCo links it to apheresis and starting-material collection and to closed automated cell therapy manufacturing. Whether apheresis capacity, rather than manufacturing, becomes the limiting step as CAR-T demand grows is the open question its position highlights. The apheresis technology page carries the wider picture.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Lakewood, CO
- Type: devices
- Website: https://www.terumobct.com

## Sources

- Official website: https://www.terumobct.com

## Connected records

- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/)
- technologies: [Apheresis and starting-material collection](https://onco.cc/technologies/apheresis-starting-material/), [Closed automated cell-therapy manufacturing](https://onco.cc/technologies/closed-automated-cell-manufacturing/)

---
JSON: https://onco.cc/api/v1/entities/terumo-bct.json